Patron Exim Ltd

AGM Details

• Date: 30 September 2026; Time: 04:00 PM; Mode: VC/OAVM
• E-voting window: 27–29 September 2026; ends 5:00 PM
• Meeting concluded at 4:15 PM
• Quorum present; documents available electronically

Key Resolutions

• Adopt the financial statements and reports for the year ended 31 March 2026
• Re-appoint Narendrakumar Gangaramdas Patel as Managing Director (retires by rotation)
• Appoint A. Shubhangi & Associates as Secretarial Auditor

Voting & Results

• Voting outcomes not disclosed; to be declared and communicated to exchanges

Auditor Appointments

• Secretarial Auditor appointed: A. Shubhangi & Associates

Patron Exim Limited: Closure of Trading Window from October 01, 2026 till the completion of 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ended September 30, 2026

Financials

• Revenue from operations: Rs 2,420.85 lakh in FY2025-26.
• Total revenue: Rs 2,429.52 lakh in FY2025-26.
• Profit after tax: Rs -108.96 lakh in FY2025-26.
• Earnings per share: Rs 0.03 for FY2025-26.
• Cash flow from operations: Rs -201.25 lakh in FY2025-26.
• Dividend declared: none for FY2025-26.

Business and operations

• Product portfolio comprises around 150 APIs, excipients, pharma chemicals, and intermediates.
• Geography: operations concentrated in Ahmedabad and surrounding Gujarat.
• Certifications include ISO 9001:2015, ISO 22000:2018, ISO 45001:2018, HALAL, WHO-GMP.
• Trading shift: moved to castor and castor oil in FY2025-26.

Capital and dividends

• Authorised capital Rs 25 crore; paid-up capital Rs 23.18 crore.
• Shares outstanding: 23.18 million equity shares.
• Top holders: Narendrakumar Patel 9.59%, Sushilaben Patel 10.45%.
• Current liabilities include short-term borrowings Rs 208.81 lakh and trade payables Rs 716.81 lakh.

Governance and people

• MD Narendrakumar Gangaramdas Patel appointed November 2024 and continues as MD.
• Sumitkumar Patel resigned on 29-05-2026.
• Secretarial Auditor A. Shubhangi & Associates appointed for FY2026-27 to FY2030-31.
• Auditors JM Patel & Bros; issued a qualified opinion on FY2025-26.
• AGM scheduled for 30 September 2026; held via VC/OAVM with e-voting.

Audit & compliance

• Internal audit: no internal auditor appointed in FY2025-26.
• Secretarial audit notes delays in statutory filings; Annexure C included.
• Tax/GST: outstanding tax demands observed; contingent liabilities not fully disclosed.
• Secretarial and governance disclosures are being updated; website disclosures flagged for update.

Market outlook and risks

• Global API market: $255B in 2024; projected $359B by 2030; CAGR 5.8%.
• Indian API market: $19.21B in 2025; projected $41.60B by 2034; CAGR 7.78%.
• Govt initiatives: PLI scheme, Bulk Drug Parks, and domestic manufacturing push.

Shareholder information

• Annual return is available on the company website.
• Promoter holdings shown: Narendrakumar Patel 9.59%, Sushilaben Patel 10.45%.

Key Decisions

• Approved Draft Directors' Report for FY ended 31 Mar 2026.
• AGM fixed for 30 Sep 2026 at 04:00 PM via VC/OAVM; deemed venue at Registered Office.
• Remote e-voting: 27–29 Sep 2026; cut-off date 23 Sep 2026.
• Scrutinizer appointed: Mrs. Shubhangi Rajkumar Agarwal, Practicing Company Secretary.

Appointments/Resignations

• Secretarial Auditor: M/s A. Shubhangi & Associates for 5-year term FY2026-27 to FY2030-31; effective 08 Sep 2026.
• Profile: Shubhangi Agarwal, CS; 5+ years' experience.

Dematerialisation/rematerialisation status

• No dematerialisation/rematerialisation requests were received during the period.
• No physical certificates were mutilated or cancelled; no depository substitution occurred within the prescribed timeline.
• No exceptions, delays, or non-compliance were reported.

Financial results

• Approved audited standalone financial results for half year and year ended March 31, 2026.
• Auditor issued a qualified opinion on the audited standalone results.
• Standalone revenue from operations was Rs 2,420.85 lakh; net loss was Rs 108.96 lakh.
• Standalone total assets were Rs 4,870.36 lakh; total liabilities were Rs 1,058.54 lakh.

Audit qualifications

• Auditor highlighted related-party loans and advances increased to Rs 28.78 crore.
• Auditor noted unpaid TDS of Rs 34.45 lakh and pending tax demands.
• Auditor reported non-compliance with audit trail requirements and no internal audit activity.
• Auditor cited unverifiable supporting records, doubtful advances to creditors, and stock verification concerns.

Other disclosures

• Company reported one business segment: trading of chemicals.
• No investor complaints were pending as of March 31, 2026.

Resignation

• Mr. Sumitkumar Jayantibhai Patel resigned as Non-Executive Independent Director, effective close of business on June 1, 2026.
• Reason stated was personal reasons and other professional commitments.
• He confirmed no other material reasons for resignation.
• He also ceased as Chairman of the Audit, Nomination and Remuneration, and Stakeholders Relationship Committees.
• He holds independent directorships at Siddhi Costpin Limited, Orbit Pharma Limited, and SVS Ventures Limited.

Meeting Details

• Board meeting scheduled for Monday, 11 May 2026.

Key Agenda Items

• Approve audited financial results for half year and year ended 31 March 2026.
• Take note of the auditors' report on those audited results.